# OnCo record peace-3 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/peace-3/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "peace-3", "NCT02194842" ;
  schema:name "PEACE-3 (EORTC 1333)"@en ;
  schema:alternateName "PEACE-3"@en, "PEACE III"@en, "EORTC 1333-GUCG"@en ;
  schema:description "Combining the bone-seeking radioactive drug radium-223 with enzalutamide made men live about six months longer, and the fractures that sank the earlier version of this idea were prevented by giving bone-protecting drugs to everyone."@en ;
  schema:url <https://onco.cc/trials/peace-3/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02194842>, <https://doi.org/10.1016/j.annonc.2026.02.009>, <https://www.nice.org.uk/guidance/ta412> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/targeted-alpha-therapy/>, <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/radium-223/>, <https://onco.cc/drugs/enzalutamide/>, <https://onco.cc/drugs/denosumab/>, <https://onco.cc/drugs/zoledronic-acid/> ;
  onco:companies <https://onco.cc/companies/curie-nki-eortc/>, <https://onco.cc/companies/bayer/> ;
  onco:terms <https://onco.cc/terms/bone-metastases/>, <https://onco.cc/terms/castration-resistance/>, <https://onco.cc/terms/arpi/> ;
  onco:trials <https://onco.cc/trials/era-223/>, <https://onco.cc/trials/alsympca/>, <https://onco.cc/trials/vision/> .